Report Detail
Global Addictions Therapeutics Market Size, Status and Forecast 2019-2025
- RnM3798991 |
- 02 October, 2019 |
- Global |
- 91 Pages |
- QYResearch |
- Other
This report focuses on the global Addictions Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Addictions Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Alkermes Plc
Amneal Pharmaceuticals Inc.
Indivior Plc
Johnson & Johnson Services Inc.
Mylan NV
Novartis AG
Novo Nordisk AS
Opiant Pharmaceuticals Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Market segment by Type, the product can be split into
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
Market segment by Application, split into
Public
Private
Government
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Addictions Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Addictions Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Addictions Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Addictions Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Alcohol Addiction Therapeutics
- 1.4.3 Tobacco Addiction Therapeutics
- 1.4.4 Drug Addiction Therapeutics
- 1.5 Market by Application
- 1.5.1 Global Addictions Therapeutics Market Share by Application (2019-2025)
- 1.5.2 Public
- 1.5.3 Private
- 1.5.4 Government
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Addictions Therapeutics Market Size
- 2.2 Addictions Therapeutics Growth Trends by Regions
- 2.2.1 Addictions Therapeutics Market Size by Regions (2019-2025)
- 2.2.2 Addictions Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Addictions Therapeutics Market Size by by Players
- 3.1.1 Global Addictions Therapeutics Revenue by by Players (2014-2019)
- 3.1.2 Global Addictions Therapeutics Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Addictions Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Addictions Therapeutics Key Players Head office and Area Served
- 3.3 Key Players Addictions Therapeutics Product/Solution/Service
- 3.4 Date of Enter into Addictions Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Addictions Therapeutics Market Size by Type (2014-2019)
- 4.2 Global Addictions Therapeutics Market Size by Application (2014-2019)
5 North America
- 5.1 North America Addictions Therapeutics Market Size (2014-2019)
- 5.2 Addictions Therapeutics Key Players in North America
- 5.3 North America Addictions Therapeutics Market Size by Type
- 5.4 North America Addictions Therapeutics Market Size by Application
6 Europe
- 6.1 Europe Addictions Therapeutics Market Size (2014-2019)
- 6.2 Addictions Therapeutics Key Players in Europe
- 6.3 Europe Addictions Therapeutics Market Size by Type
- 6.4 Europe Addictions Therapeutics Market Size by Application
7 China
- 7.1 China Addictions Therapeutics Market Size (2014-2019)
- 7.2 Addictions Therapeutics Key Players in China
- 7.3 China Addictions Therapeutics Market Size by Type
- 7.4 China Addictions Therapeutics Market Size by Application
8 Japan
- 8.1 Japan Addictions Therapeutics Market Size (2014-2019)
- 8.2 Addictions Therapeutics Key Players in Japan
- 8.3 Japan Addictions Therapeutics Market Size by Type
- 8.4 Japan Addictions Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Addictions Therapeutics Market Size (2014-2019)
- 9.2 Addictions Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia Addictions Therapeutics Market Size by Type
- 9.4 Southeast Asia Addictions Therapeutics Market Size by Application
10 India
- 10.1 India Addictions Therapeutics Market Size (2014-2019)
- 10.2 Addictions Therapeutics Key Players in India
- 10.3 India Addictions Therapeutics Market Size by Type
- 10.4 India Addictions Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America Addictions Therapeutics Market Size (2014-2019)
- 11.2 Addictions Therapeutics Key Players in Central & South America
- 11.3 Central & South America Addictions Therapeutics Market Size by Type
- 11.4 Central & South America Addictions Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 Alkermes Plc
- 12.1.1 Alkermes Plc Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Addictions Therapeutics Introduction
- 12.1.4 Alkermes Plc Revenue in Addictions Therapeutics Business (2014-2019))
- 12.1.5 Alkermes Plc Recent Development
- 12.2 Amneal Pharmaceuticals Inc.
- 12.2.1 Amneal Pharmaceuticals Inc. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Addictions Therapeutics Introduction
- 12.2.4 Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2014-2019)
- 12.2.5 Amneal Pharmaceuticals Inc. Recent Development
- 12.3 Indivior Plc
- 12.3.1 Indivior Plc Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Addictions Therapeutics Introduction
- 12.3.4 Indivior Plc Revenue in Addictions Therapeutics Business (2014-2019)
- 12.3.5 Indivior Plc Recent Development
- 12.4 Johnson & Johnson Services Inc.
- 12.4.1 Johnson & Johnson Services Inc. Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Addictions Therapeutics Introduction
- 12.4.4 Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2014-2019)
- 12.4.5 Johnson & Johnson Services Inc. Recent Development
- 12.5 Mylan NV
- 12.5.1 Mylan NV Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Addictions Therapeutics Introduction
- 12.5.4 Mylan NV Revenue in Addictions Therapeutics Business (2014-2019)
- 12.5.5 Mylan NV Recent Development
- 12.6 Novartis AG
- 12.6.1 Novartis AG Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Addictions Therapeutics Introduction
- 12.6.4 Novartis AG Revenue in Addictions Therapeutics Business (2014-2019)
- 12.6.5 Novartis AG Recent Development
- 12.7 Novo Nordisk AS
- 12.7.1 Novo Nordisk AS Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Addictions Therapeutics Introduction
- 12.7.4 Novo Nordisk AS Revenue in Addictions Therapeutics Business (2014-2019)
- 12.7.5 Novo Nordisk AS Recent Development
- 12.8 Opiant Pharmaceuticals Inc.
- 12.8.1 Opiant Pharmaceuticals Inc. Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Addictions Therapeutics Introduction
- 12.8.4 Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2014-2019)
- 12.8.5 Opiant Pharmaceuticals Inc. Recent Development
- 12.9 Pfizer Inc.
- 12.9.1 Pfizer Inc. Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Addictions Therapeutics Introduction
- 12.9.4 Pfizer Inc. Revenue in Addictions Therapeutics Business (2014-2019)
- 12.9.5 Pfizer Inc. Recent Development
- 12.10 Teva Pharmaceutical Industries Ltd.
- 12.10.1 Teva Pharmaceutical Industries Ltd. Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Addictions Therapeutics Introduction
- 12.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2014-2019)
- 12.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Addictions Therapeutics. Industry analysis & Market Report on Addictions Therapeutics is a syndicated market report, published as Global Addictions Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Addictions Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
